Skip to content

REVANDO

Active
Private limited company·Activiteiten van tandartspraktijken· 4 yrs active
Marie Popelinlaan 2 ·3001 Leuven, Belgium
KBO/BCE: BE 0787.828.852
Watch Print / PDF
Full dossier in preparation

Checked processes every Belgian company, act by act, from the Belgian Official Gazette. The data below is real and verified, this company's full, act-by-act verified dossier is still being assembled.

Process with priority Sign in free to move this company to the front.
Age4 yrs

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of REVANDO is 0.2% (very low). The 2025 annual accounts show equity of €3k and a net result of €69k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 16% of 2209 sector peers (fiscal year 2025). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 4 annual accounts.

Signals

2 signals · with evidence
Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 16% of 2209 sector peers (2025).
View the sector comparison
Consistently profitable
Positive net result in the two most recent financial years (2024 and 2025).
View the result trend

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Filing behaviour

From the deposit records, complete market-wide
Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 09-04-2026, 113 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.
The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
How we compute the deadline
The year end is derived from 4 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2025, that is 31-07-2026.
Deadline per financial year
Year closed Due by Filed Variance Reference
31-12-2025 31-07-2026 09-04-2026 113 d early 2026-00075501
31-12-2024 31-07-2025 26-06-2025 35 d early 2025-00179766
31-12-2023 31-07-2024 26-07-2024 5 d early 2024-00286217
31-12-2022 31-07-2023 03-07-2023 28 d early 2023-00197119

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals
More than 3 years active
Founded in 2022, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
0.2% Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector Young company +Annual accounts: healthy financial profile

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€69k-3.6%
Working capital€-2k

Annual accounts & ratios

Source: NBB · 2025
Annual accounts filed on 09-04-2026 with the NBB · fiscal year 2025 · micro
€0€25k€50k€75k€100kOperating result 2022: €21k€21kNet result 2022: €16k€16kOperating result 2023: €65k€65kNet result 2023: €48k€48kOperating result 2024: €96k€96kNet result 2024: €71k€71kOperating result 2025: €88k€88kNet result 2025: €69k€69k2022202320242025
Operating resultNet result
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
volatile Too volatile to project: the yearly deviation from the trend is ~79% of the level (threshold 35%). We therefore deliberately show no projection line.
€0€50k€100k€150k2022: €19k2023: €67k2024: €139k2025: €3k2022202320242025
How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison
Fiscal year 2025 · NACE 86, Human health · compared within the same schema type (micro schema)
Metric This company Sector median Position in the sector
Solvency 3.8% 58.2%
better than 16% of 2209 sector peers
Net result €69k €60k
better than 55% of 2207 sector peers
Equity €3k €74k
better than 12% of 2209 sector peers
Gross operating margin €92k €96k
better than 48% of 2209 sector peers
Total assets €78k €187k
better than 19% of 2209 sector peers
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
Sector position over time
Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).
Solvency P16
2022: P66 · n=36672023: P71 · n=53292024: P76 · n=65732025: P16 · n=22092022 2025
Weakening position over 2022-2025 · n=2209-6573
Net result P55
2022: P28 · n=36652023: P58 · n=53282024: P65 · n=65672025: P55 · n=22072022 2025
Improving position over 2022-2025 · n=2207-6567
Equity P12
2022: P23 · n=36672023: P50 · n=53312024: P68 · n=65732025: P12 · n=22092022 2025
Improving position over 2022-2025 · n=2209-6573
Gross operating margin P48
2022: P21 · n=36632023: P51 · n=53252024: P59 · n=65752025: P48 · n=22092022 2025
Improving position over 2022-2025 · n=2209-6575
Describes the position versus peers, not a forecast.
EBITDA
€91k
-8.3% 22-25
Net profit
€69k
-3.6% 22-25
Cash flow
€72k
-3.5% 22-25
Total assets
€78k
-52.7% 22-25
Equity
€3k
-97.8% 22-25
Working capital
€-2k
- 22-25
Income taxes
€18k
-26.9% 22-25
Dividends
€204k
- 22-25
Debt
€75k
+180.0% 22-25
Debt ≤ 1y
€75k
+180.0% 22-25
Current ratio
0.97
-83.5% 22-25
Quick ratio
0.97
-83.5% 22-25
Solvency
3.8%
-95.4% 22-25
Debt / equity
25.07
+12830.8% 22-25
ROE
2294.7%
+4351.4% 22-25
ROA
88.0%
+103.8% 22-25
Interest coverage
88.05
-96.1% 22-25
Figures by fiscal year
Fiscal year2025
Depositmicro
Revenue-
EBITDA€91k
Net profit€69k
Cash flow€72k
Staff costs-
Income taxes€18k
Dividends€204k
Total assets€78k
Equity€3k
Debt€75k
of which ≤ 1y€75k
of which > 1y-
Working capital€-2k
Employees (FTE)-
Ratios (computed)
2025
Current ratio0.97
Quick ratio0.97
Working capital ratio-3.1%
Solvency3.8%
Debt / equity25.07
Long-term debt ratio-
Interest coverage88.05
Gross margin-
Net margin-
ROA88.0%
ROE2294.7%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2025
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2025
Balance sheet, Assets
TOTAL ASSETS 20/58€78k
Fixed assets 21/28€5k
Tangible fixed assets 22/27€5k
Current assets 29/58€73k
Cash & bank 54/58€66k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€78k
Equity 10/15€3k
Contributions / capital 10/11€3k
Amounts payable 17/49€75k
Amounts payable within one year 42/48€75k
Income statement
Gross operating margin 9900€92k
Operating result 9901€88k
Financial income 75€0
Financial charges 65€1k
Result before taxes 9903€87k
Income taxes 67/77€18k
Net result for the period 9904€69k
Result to be appropriated 9905€69k
You're seeing the latest fiscal year only. Unlock 3 prior years (figures + ratios) with a paid plan. See plans →
Ratios computed by Checked.

Health barometer

FY 2025 · computed
45 / 100 Fair
050100
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.

See plans →
Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.

Structure & network

Locations & real estate

Registered office

on the map · from the address register
exact location from the address register On OpenStreetMap

Establishment units

1 location
Marie Popelinlaan 2, 3001 Leuven
Activiteiten van tandartspraktijken
since 20222.334.578.281
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area518 m²
Buildings1
Building footprint111 m²

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
24040C0167/00F000 Flanders 518 m² 1 · 111 m² -
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgisch Staatsblad · acts

1 acts
Address history · 1
06-06-2025
Registered-office move
All acts · 1 updated 1 year ago
2025
06-06-2025 Registered office moved from Heverlee to Leuven Registered-office change
  • Armand Thiérylaan 66, 3001 Heverlee → Marie Popelinlaan 2, 3001 Leuven

Analysis

Snowflake analysis

financial profile on 5 axes
Health45Profitability100Solvency13Growth58Stability94
62 / 100

Strong profile, led by profitability.

All 5 axes are computed from data Checked has read.

Health 45
Profitability 100
Solvency 13
Growth 58
Stability 94

Ask AI about this company

Checked AI

Soon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.

TryWhat are the main risks?Any recent red flags?Compare to sector peers
Coming soon

AI due-diligence brief

Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works

Credit advice

verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Same sector, ranked by comparable size

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Tandartspraktijken86230Activiteiten van tandartspraktijken86230Schoonheidsverzorging96022Schoonheidsverzorging en andere schoonheidsbehandelingen96220
Primary activity highlighted.
Names & trade names
Legal nameNL REVANDO
Registered office
Marie Popelinlaan 2
3001 Leuven, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.